| Issue Date |
Title |
Author(s) |
| Aug-2021 |
Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer |
Li, Huiping;Song, Guohong;Zhou, Qiaoxia;Ran, Ran;Jiang, Hanfang;Zhang, Ruyan;Liu, Yaxin;Zhang, Jiayang;Meng, Luping;Ma, Liandong;Sun, Ye;Wang, Meiyu;Zhou, Qingqing;Yan, Honghua;Zhou, Qianxiang;Dong, Xunwei;Tong, Youzhi |
| Feb-2020 |
Apatinib in the treatment of HER-2 negative advanced breast cancer with chest wall metastasis multicenter phase II clinical study |
Li, Huiping;Geng, Cuizhi;Song, Guohong;Jiang, Hanfang;Tong, Zhongshen;Yang, Junlan;Ran, Ran;Zhang, Ruyan;Liu, Yaxin;Gui, Xinyu;Wei, Maorong;Xue, Lu |
| 2018 |
Bilateral breast cancer in China: A 10-year single-center retrospective study |
Li, Huiping;Jiang, Hanfang;Zhang, Ruyan;Shao, Bin;Yan, Ying;Ran, Ran;Di, Lijun |
| 2018 |
Bilateral breast cancer in China: A 10-year single-center retrospective study |
Li, Huiping;Jiang, Hanfang;Zhang, Ruyan;Shao, Bin;Yan, Ying;Ran, Ran;Di, Lijun |
| 2018 |
Biomarker analysis by next generation circulating tumor DNA (ctDNA) sequencing in patients with advanced breast cancer |
Li, Huiping;Wang, Jing;Rugo, Hope S.;Zhang, Yan;Yang, Ling;Liu, Xiaoran;Shao, Bin;Xu, Yaping;Yang, Liang;Zhang, Ruyan;Ran, Ran;Chang, Lianpeng |
| 2018 |
Biomarker analysis by next generation circulating tumor DNA (ctDNA) sequencing in patients with advanced breast cancer |
Li, Huiping;Wang, Jing;Rugo, Hope S.;Zhang, Yan;Yang, Ling;Liu, Xiaoran;Shao, Bin;Xu, Yaping;Yang, Liang;Zhang, Ruyan;Ran, Ran;Chang, Lianpeng |
| 2018 |
Combination versus sequential paclitaxel plus gemcitabine as first-line chemotherapy for women with metastatic breast cancer: a prospective randomized phase II study |
Shao, Bin;Song, Guohong;Li, Huiping;Di, Lijun;Jiang, Hanfang;Liang, Xu;Yan, Ying;Zhang, Ruyan;Ran, Ran;Wang, Jing;Liu, Xiaoran;You, Miaoning |
| 2020 |
Efficacy and Safety of Fulvestrant 500mg in Hormone-receptor Positive Human Epidermal Receptor 2 Negative Advanced Breast Cancer: A Real-world Study in China |
Lei, Wen;Li, Huiping;Song, Guohong;Zhang, Ruyan;Ran, Ran;Yan, Ying;Di, Lijun;Jiang, Hanfang |
| Feb-2020 |
Efficacy observation of 306 patients with fulvestrant 500mg treatment in hormone-receptor positive HER2 negative metastasis breast cancer, a real world study |
Lei, Wen;Li, Huiping;Song, Guohong;Zhang, Ruyan;Ran, Ran;Yan, Ying |
| 13-Apr-2022 |
Germline Mutational Landscape in Chinese Patients With Advanced Breast Cancer |
Zhang, Jiayang;Wang, Nan;Zheng, Tiantian;Lu, Tan;Zhang, Ruyan;Ran, Ran;Li, Kun;Huang, Yong;Xie, Feng;Zhang, Yue;Jia, Shidong;Yu, Jianjun;Li, Huiping |
| 1-May-2021 |
Molecular dynamics investigation of the slip flow liquid-solid interfacial thermal conductance |
Wang, Zhenyu;Sun, Shangwei;Cui, Yifan;Ran, Ran;Zhao, Yongzhi |
| Feb-2021 |
Peripheral cytotoxic T lymphocyte predicts first-line progression free survival in HER2-positive advanced breast cancer |
Liu, Xiao-Ran;Yu, Jian-Jun;Song, Guo-Hong;Di, Li-Jun;Jiang, Han-Fang;Yan, Ying;Liang, Xu;Zhang, Ru-Yan;Ran, Ran;Wang, Jing;Bai, Han;Jia, Shi-Dong;Li, Hui-Ping |
| 20-May-2021 |
A phase Ib study of proxalutamide (GT0918) in women with androgen receptor-positive metastatic breast cancer. |
Li, Huiping;Jiang, Hanfang;Yin, Yongmei;Tong, Zhongsheng;Ouyang, Quchang;Shen, Kunwei;Yuan, Zhongyu;Geng, Cuizhi;Ran, Ran;Zhang, Ruyan;Liu, Ya-Xin;Zhang, Jiayang;Li, Wei;Qu, Qing;Zhou, Qiaoxia;Dong, Xunwei;Meng, Luping;Zhu, Xiaoyan;Yi, Zhen;Tong, Youzhi |
| 2018 |
Plasma PIK3CA ctDNA specific mutation detected by next generation sequencing is associated with clinical outcome in advanced breast cancer |
Li, Huiping;Xu, Yaping;Zhao, Fangyuan;Song, Guohong;Rugo, Hope S.;Zhang, Yan;Yang, Ling;Liu, Xiaoran;Shao, Bin;Yang, Liang;Liu, Yaxin;Ran, Ran;Zhang, Ruyan;Guan, Yanfang;Chang, Lianpeng;Yi, Xin |
| Apr-2021 |
Prognostic factors for patients with metastatic breast cancer: a literature review |
Hu, Mengyu;Shao, Bin;Ran, Ran;Li, Huiping |
| 2020 |
Prognostic Value of Plasma HER2 Gene Copy Number in HER2-Positive Metastatic Breast Cancer Treated with First-Line Trastuzumab |
Ran, Ran;Huang, Wenfa;Liu, Yaxin;Shao, Lin;Liu, Xiaoran;Niu, Yunyun;Kong, Weiyao;Bo, Shiping;Rugo, Hope S.;Lu, Sijia;Li, Huiping |
